U.S. Extends COVID-19 Public Health Emergency Another Three Months

MONDAY, July 18, 2022 (HealthDay News) -- As the latest omicron subvariant fuels climbing case counts in the United States, the Biden administration has extended the country's public health emergency status through mid-October.
Known as BA.5, the subvariant is considered the most contagious to date, and officials from the U.S. Centers for Disease Control and Prevention say they expect hospitalizations to increase. CDC data show that nearly half of the country's population lives in a county with a "high COVID-19 Community Level," where the health care system is at risk of becoming overburdened and indoor masking is recommended.
"The Public Health Emergency (PHE) declaration continues to provide us with tools and authorities needed to respond to the highly transmissible COVID-19 subvariants that are currently circulating around the country," a Biden administration official told CNN. "The PHE provides essential capabilities and flexibilities to hospitals to better care for patients, particularly if we were to see a significant increase in hospitalizations in the coming weeks."
The declaration also impacts the testing and treatments people can receive, which will end for some once the public health emergency is declared over. Among those services are free COVID-19 testing, treatments, and vaccines. Vaccinations would generally continue to be free for those covered by Medicare and private insurance, according to CNN. Those enrolled in state Medicaid programs would have coverage decided on by their states.
During the health emergency, Medicare has offered more leniency with telehealth visits, not limiting them to those living in rural areas. Enrollees can now access more health care services without leaving home than they previously could.
A separate emergency declaration allows for the emergency use authorization of testing, treatments, and vaccines, CNN reported. Its end date will be determined by the U.S. Department of Health and Human Services with 60 days notice.
Related Posts
Study Debunks Use of Antidepressant Luvox as COVID Treatment
THURSDAY, Oct. 20, 2022 (HealthDay News) -- A study testing drugs that are used...
FDA Approves Drug for Cats With Allergic Skin Disease
FRIDAY, March 31, 2023 (HealthDay News) -- Cats constantly licking and chewing...
Small Risk Found for Some Congenital Anomalies With Opioid Exposure
MONDAY, Feb. 7, 2022 (HealthDay News) -- There is a small increased risk for...
American Association for Cancer Research, April 14-19
The annual meeting of the American Association for Cancer Research was held...
